Promising results from 4Life clinical research
4Life has released a technical white paper titled “Clinical Study on Rapid Modulating Effects of 4Life Transfer Factor Max on Immune Stem Cells”, analyzing the impact of its flagship product on the immune system.
The study was conducted in two phases and evaluated 4Life Transfer Factor Max in healthy adults who had never previously taken transfer factor products. Participants received either the product or a placebo, followed by blood samples taken three times per hour.
One week later, participants returned and repeated the process using the opposite treatment.
Study methodology
The main objective was to directly compare the effects of 4Life Transfer Factor Max against a placebo under controlled conditions.
This design allowed researchers to closely monitor cellular markers and immune system responses within a short timeframe.
Cellular activation and immune response
According to Dr. Brent Vaughan, Senior Vice President of Research & Development at 4Life:
“The results were quite positive. Within hours, participants who consumed 4Life Transfer Factor Max showed a notable increase in cell surface markers, indicating cellular activation and stem cell mobilization into tissues.”
These findings suggest that the product may trigger a short-term systemic immune response, a key factor in immune support.
Study implications
4Life stated that participants who consumed the product experienced increased immune system activity compared to the placebo group.
While these are early findings, the study provides meaningful insights into the product’s potential role in immune modulation.
Source: Direct Selling News
